Form 4 for AVNT AVIENT CORP
Accepted 2024-09-04 00:00:00 ET · period of report 2024-08-30 · accession 0001127602-24-023388 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-08-30 | AVNT | Midea M. John Jr. | SVP, Glbl Ops, Process Imprv | F - Tax | $49.05 | -36.9K | 30.9K | -54% | -$1.81M |
| DM | 2024-09-04 | 2024-08-30 | AVNT | Midea M. John Jr. | SVP, Glbl Ops, Process Imprv | M - OptEx | $32.17 | +47.0K | 40.3K | New | +$1.51M |
| DM | 2024-09-04 | 2024-08-30 | AVNT | Midea M. John Jr. | SVP, Glbl Ops, Process Imprv | M - OptEx | $0.00 | -47.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-30 | F | D | 14,858 | $49.01 | 38,424 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-30 | M | A | 18,550 | $31.48 | 53,282 | D | — | — | |
| 3 | Common | Common Stock | 2024-08-30 | F | D | 12,693 | $49.07 | 34,732 | D | — | — | |
| 4 | Common | Common Stock | 2024-08-30 | M | A | 16,500 | $31.54 | 47,425 | D | — | — | |
| 5 | Common | Common Stock | 2024-08-30 | M | A | 11,950 | $34.10 | 40,300 | D | — | — | |
| 6 | Common | Common Stock | 2024-08-30 | F | D | 9,375 | $49.07 | 30,925 | D | — | — | |
| 7 | Derivative | Stock Appreciation Rights | 2024-08-30 | M | D | 11,950 | $0.00 | 0 | D | $34.10 · — to 2027-02-15 | 11,950 Common Stock | (F2) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $34.10 per share and no more than one-third of the grant can vest per year during the first three years. |
| 8 | Derivative | Stock Appreciation Rights | 2024-08-30 | M | D | 16,500 | $0.00 | 0 | D | $31.54 · — to 2029-02-11 | 16,500 Common Stock | (F3) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years. |
| 9 | Derivative | Stock Appreciation Rights | 2024-08-30 | M | D | 18,550 | $0.00 | 0 | D | $31.48 · — to 2030-02-10 | 18,550 Common Stock | (F4) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years. |